Drug Profile
CE 224535
Alternative Names: CE-224,535Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Pfizer
- Class Analgesics; Anti-inflammatories; Antirheumatics
- Mechanism of Action Purinergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Osteoarthritis; Rheumatoid arthritis
Most Recent Events
- 31 Mar 2009 Discontinued - Phase-II/III for Rheumatoid arthritis in Chile (PO)
- 31 Mar 2009 Discontinued - Phase-II/III for Rheumatoid arthritis in Czech Republic (PO)
- 31 Mar 2009 Discontinued - Phase-II/III for Rheumatoid arthritis in Mexico (PO)